Pulmonary atresia medical therapy

Revision as of 20:13, 1 November 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com, -kfeeney@perfuse.org +kfeeney@elon.edu))
Jump to navigation Jump to search

Pulmonary atresia Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary atresia from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Labratory findings

Electrocardiogram

Chest X Ray

MRI

Echocardiography or Ultrasound

CT Scan

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Pulmonary atresia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulmonary atresia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary atresia medical therapy

CDC on Pulmonary atresia medical therapy

Pulmonary atresia medical therapy in the news

Blogs on Pulmonary atresia medical therapy

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pulmonary atresia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2], Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]

Overview

A patient with pulmonary atresia will require immediate intervention. Intravenous medical therapies may be employed as a supportive mechanism to assist in improvement of hemodynamics, as well as cardiovascular and pulmonary functioning.

Medical Therapy

An IV medication called prostaglandin E1 is used for treatment of pulmonary atresia. This medication helps the blood circulate through the body, but it is extremely dangerous because it causes apnea. In pulmonary atresia treatment it is intended for use to assist the heart and lung functioning temporarily until surgical intervention can occur.

References


Template:WikiDoc Sources